v3.23.1
Condensed Consolidated Balance Sheets - USD ($)
Mar. 31, 2023
Dec. 31, 2022
Current Assets:    
Cash and cash equivalents $ 11,827,956 $ 14,739,484
Accounts receivable, net 98,132 135,658
Prepaid expenses and other current assets 313,606 346,935
Total Current Assets 12,239,694 15,222,077
Deferred financing costs 10,000 10,000
Total Assets 12,249,694 15,232,077
Current Liabilities:    
Accounts payable - suppliers 386,497 673,781
Accounts payable - trade 776,545 816,190
Accrued expenses and other current liabilities 557,964 830,365
Deferred revenue 567 28,403
Total Current Liabilities 1,721,573 2,348,739
Notes payable 78,900 78,900
Total Liabilities 1,800,473 2,427,639
Commitments and contingencies
Stockholders' Equity:    
Preferred stock, $0.00001 par value; 5,000,000 shares authorized; No shares issued and outstanding as of March 31, 2023 and December 31, 2022
Common stock, $0.00001 par value; 95,000,000 shares authorized; 14,515,940 and 14,456,035 shares issued and outstanding as of March 31, 2023 and December 31, 2022, respectively 145 145
Additional paid-in capital 53,115,414 53,004,967
Accumulated deficit (42,666,338) (40,200,674)
Total Stockholders' Equity 10,449,221 12,804,438
Total Liabilities and Stockholders' Equity $ 12,249,694 $ 15,232,077

Source